# Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects

> **NCT00413426** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 28 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Darifenacin (DAR328)

## Key facts

- **NCT ID:** NCT00413426
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 28 (—)
- **Last updated:** 2016-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413426, "Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00413426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*